Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioextrax ABFRA:85X0 -0.88%48 PS Ratio is 113.00 as of Jul. 25, 2026, which is 30% below its 10-year median of 161.01. GuruFocus rates FRA:85X0 with a GF Score™ of 48/100 and a GF Value™ of €0.16 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 234 Waste Management companies, Bioextrax AB ranks worse than 98.29% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Bioextrax AB's share price is €0.226.
Bioextrax AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00. Hence, Bioextrax AB's PS Ratio for today is 113.00.
The historical rank and industry rank for Bioextrax AB's PS Ratio or its related term are showing as below:
FRA:85X0'
s PS Ratio Range Over the Past 10 Years
Min: 23.67 Med: 161.01 Max: 50476.35
Current: 119.9
During the past 10 years, Bioextrax AB's highest PS Ratio was 50476.35. The lowest was 23.67. And the median was 161.01.
FRA:85X0's PS Ratio is ranked worse than 98.29% of 234
companies
in the Waste Management industry
Industry Median: 1.765
vs FRA:85X0: 119.90
Bioextrax AB revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Bioextrax AB was 31.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -6.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 54.70% per year.
During the past 10 years, Bioextrax AB's highest 3-Year average Revenue per Share Growth Rate was 325.40% per year. The lowest was -7.20% per year. And the median was -3.10% per year.
Back to Basics: PS Ratio
Bioextrax AB (FRA:85X0) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Bioextrax AB PS Ratio Related Terms
Bioextrax AB PS Ratio Historical Data
* Premium members only.
The historical data trend for Bioextrax AB's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Waste Management subindustry, Bioextrax AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioextrax AB PS Ratio vs Waste Management Industry
For the Waste Management industry and Industrials sector, Bioextrax AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where Bioextrax AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Bioextrax AB's PS Ratio for today is calculated as
Bioextrax AB's Share Price of today is €0.226. Bioextrax AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Bioextrax AB (FRA:85X0) has a PS Ratio of 113.00 as of Jul. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Bioextrax AB and its competitors. This is 30% below median its historical median of 161.01. Over the past decade, Bioextrax AB's PS Ratio has ranged from 23.67 to 50,476.35. According to the industry distribution chart, Bioextrax AB ranks #230 out of 234 companies in the Waste Management industry, placing it in the top 98.3%.
Is Bioextrax AB's PS Ratio too high?
Bioextrax AB's current PS Ratio of 113.00 is 30% below median its 10-year median of 161.01. Over the past 10 years, this metric has ranged from a low of 23.67 to a high of 50,476.35. The Waste Management industry median PS Ratio is 1.77. Bioextrax AB's value of 113.00 is 6302.3% above this industry median. Based on the distribution chart, Bioextrax AB ranks #230 out of 234 companies in the Waste Management industry, which is in the bottom quartile relative to peers. Overall, Bioextrax AB has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bioextrax AB's PS Ratio compare to WM and RSG?
According to the Waste Management industry distribution chart, Bioextrax AB ranks #230 out of 234 companies for PS Ratio. This places Bioextrax AB in the lower half of its industry. The industry median PS Ratio is 1.77. Bioextrax AB's value of 113.00 is 6302.3% above this benchmark. Historically, Bioextrax AB's own PS Ratio has ranged from 23.67 to 50,476.35 over the past decade. While the company's 10-year median is 161.01 vs. the industry median of 1.77, Bioextrax AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Waste Management company?
The median PS Ratio among Waste Management companies is 1.77, based on 234 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioextrax AB's current PS Ratio of 113.00 is 6302.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Bioextrax AB and its competitors. For the Waste Management industry, the median PS Ratio is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioextrax AB's current PS Ratio is 113.00, which is 30% below median its own 10-year median of 161.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioextrax AB stock overvalued right now?
Based on GuruFocus' analysis, Bioextrax AB (FRA:85X0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.16, compared to a current price of €0.23 — trading 41.3% above its estimated fair value. The current PS Ratio is 113.00, which is 30% below median its 10-year median of 161.01 and 6302.3% above the Waste Management industry median of 1.77. Bioextrax AB's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Bioextrax AB (FRA:85X0), the current PS Ratio is 113.00 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioextrax AB (FRA:85X0) Overvalued in 2026?
Based on GuruFocus' analysis, Bioextrax AB stock appears to be overvalued.
The current stock price of €0.23 is trading 41.3% above its estimated GF Value™ of €0.16.
GuruFocus considers Bioextrax AB to be Significantly Overvalued.
Key valuation signals for FRA:85X0:
PS Ratio: 113.00 (30% below median its 10-year median of 161.01)
GF Value™: €0.16 vs. price of €0.23 (41.3% above fair value)
Industry Position: 6302.3% above the Waste Management median (#230 of 234)
No single metric tells the full story. See the FRA:85X0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:85X0 has been successfully added to your 
